See other bills
under the
same topic
                                                      PRINTER'S NO. 2836

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 2124 Session of 2001


        INTRODUCED BY SOLOBAY, BEBKO-JONES, BELARDI, BELFANTI, CAPPELLI,
           COLEMAN, COSTA, COY, CREIGHTON, CRUZ, DALLY, DeLUCA, DERMODY,
           DeWEESE, FAIRCHILD, FLEAGLE, FRANKEL, GEORGE, GRUCELA,
           HALUSKA, HARHAI, HENNESSEY, HORSEY, HUTCHINSON, JAMES,
           JOSEPHS, KELLER, LAUGHLIN, MAHER, MANN, McGEEHAN, MELIO,
           MUNDY, PALLONE, PIPPY, PISTELLA, ROONEY, SAINATO, SCRIMENTI,
           SHANER, STABACK, TANGRETTI, TIGUE, TRELLO, TURZAI, WALKO,
           C. WILLIAMS, J. WILLIAMS, WILT, WOJNAROSKI, G. WRIGHT,
           YOUNGBLOOD AND YUDICHAK, NOVEMBER 13, 2001

        REFERRED TO COMMITTEE ON HEALTH AND HUMAN SERVICES,
           NOVEMBER 13, 2001

                                     AN ACT

     1  Requiring the Department of Health to establish bloodborne
     2     pathogen standards for emergency services personnel and
     3     public employees; and establishing the Bloodborne Pathogen
     4     Fund.

     5     The General Assembly of the Commonwealth of Pennsylvania
     6  hereby enacts as follows:
     7  Section 1.  Short title.
     8     This act shall be known and may be cited as the Bloodborne
     9  Pathogen Standard Act.
    10  Section 2.  Definitions.
    11     The following words and phrases when used in this act shall
    12  have the meanings given to them in this section unless the
    13  context clearly indicates otherwise:
    14     "Bloodborne pathogen."  A pathogenic microorganism which is
    15  present in human blood and can cause disease in humans. The term

     1  includes hepatitis B virus (HBV), hepatitis C virus (HCV) and
     2  human immunodeficiency virus (HIV).
     3     "Department."  The Department of Health of the Commonwealth.
     4     "Emergency medical services."  The services utilized in
     5  responding to the needs of an individual for immediate medical
     6  care in order to prevent loss of life or the aggravation of
     7  physiological or psychological illness or injury.
     8     "Emergency services personnel."  A person, including a
     9  trained volunteer or a member of the armed forces of the United
    10  States or the National Guard, whose official or assigned
    11  responsibilities include performing or directly supporting the
    12  performance of emergency medical or rescue services or
    13  firefighting.
    14     "Employer."  An employer having emergency services personnel
    15  or public employees with occupational exposure to blood or other
    16  material potentially containing a bloodborne pathogen.
    17     "Engineered sharps injury protection."  Any of the following:
    18         (1)  A physical attribute built into a needle device used
    19     for withdrawing body fluids, accessing a vein or artery or
    20     administering medications or other fluids, which effectively
    21     reduces the risk of an exposure incident by a mechanism such
    22     as barrier creation, blunting, encapsulation, withdrawal,
    23     retraction, destruction or other effective mechanisms.
    24         (2)  A physical attribute built into any other type of
    25     needle device or into a nonneedle sharp which effectively
    26     reduces the risk of an exposure incident.
    27     "Front-line health care worker."  A nonmanagerial employee
    28  responsible for direct patient care with potential occupational
    29  exposure to a sharps injury.
    30     "Fund."  The Bloodborne Pathogen Fund established in section
    20010H2124B2836                  - 2 -

     1  4.
     2     "Needleless system."  A device which does not utilize needles
     3  for:
     4         (1)  the withdrawal of body fluids after initial venous
     5     or arterial access is established;
     6         (2)  the administration of medication or fluids; or
     7         (3)  any other procedure involving the potential for an
     8     exposure incident.
     9     "Public employee."  An employee of the Commonwealth or a
    10  political subdivision employed in a health care facility, home
    11  health care organization or other facility providing health
    12  care-related services. The term does not include a licensed
    13  individual who provides only intraoral care.
    14     "Rescue."  The act of extricating persons from entrapment or
    15  dangerous situations which pose the imminent threat of death or
    16  serious bodily injury.
    17     "Sharp."  An object used or encountered in a health care
    18  setting which can be reasonably anticipated to penetrate the
    19  skin or any other part of the body and to result in an exposure
    20  incident. The term includes a needle device, scalpel or lancet;
    21  broken glass; or a broken capillary tube.
    22     "Sharps injury."  An injury caused by a sharp. The term
    23  includes any cut, abrasion or needlestick.
    24     "Sharps injury log."  A written or electronic record of
    25  sharps injuries.
    26  Section 3.  Department.
    27     (a)  Adoption of standard.--Within six months of the
    28  effective date of this act, the department shall promulgate
    29  regulations adopting a bloodborne pathogen standard governing
    30  emergency services personnel and public employees. The standard
    20010H2124B2836                  - 3 -

     1  shall be at least as prescriptive as the standard promulgated by
     2  the Federal Occupational Safety and Health Review Commission and
     3  shall include the following:
     4         (1)  A requirement that needleless systems and sharps
     5     with engineered sharps injury protection be included as
     6     engineering and work practice controls. Engineering controls
     7     under this paragraph shall not be required if:
     8             (i)  none is available in the marketplace; or
     9             (ii)  an evaluation committee, as described in
    10         paragraph (2)(iii)(C)(X), determines by means of
    11         objective product evaluation criteria that use of such
    12         devices will jeopardize patient or employee safety with
    13         regard to a specific medical procedure.
    14         (2)  A requirement that each employer develop and
    15     implement an effective written exposure control plan which
    16     includes procedures for all of the following:
    17             (i)  Identifying and selecting needleless systems and
    18         sharps with engineered sharps injury protection through
    19         the evaluation committee described in subparagraph
    20         (iii)(C)(X).
    21             (ii)  Updating the written exposure control plan when
    22         necessary, but at least once each year, to reflect
    23         progress in implementing needleless systems and sharps
    24         with engineered sharps injury protection as determined by
    25         the evaluation committee under subparagraph (iii)(C)(X).
    26             (iii)  Recording information concerning exposure
    27         incidents in a sharps injury log. This subparagraph
    28         includes:
    29                 (A)  Date and time of the exposure incident.
    30                 (B)  Type and brand of sharp involved in the
    20010H2124B2836                  - 4 -

     1             exposure incident.
     2                 (C)  Description of the exposure incident. This
     3             clause includes:
     4                     (I)  Job classification of the exposed
     5                 emergency services personnel or public employee.
     6                     (II)  Department or work area where the
     7                 exposure incident occurred.
     8                     (III)  Procedure which the exposed emergency
     9                 services personnel or public employee was
    10                 performing at the time of the incident.
    11                     (IV)  How the incident occurred.
    12                     (V)  Body part involved in the exposure
    13                 incident.
    14                     (VI)  If the sharp had engineered sharps
    15                 injury protection, whether the protective
    16                 mechanism was activated and whether the injury
    17                 occurred before the protective mechanism was
    18                 activated, during activation of the mechanism or
    19                 after activation of the mechanism.
    20                     (VII)  If the sharp had no engineered sharps
    21                 injury protection, whether and how such a
    22                 mechanism could have prevented the injury. This
    23                 subclause requires statement of the basis for the
    24                 assessment.
    25                     (VIII)  An assessment of whether any other
    26                 engineering, administrative or work practice
    27                 control could have prevented the injury. This
    28                 subclause requires statement of the basis for the
    29                 assessment.
    30                     (IX)  Ensuring that all front-line health
    20010H2124B2836                  - 5 -

     1                 care workers are trained on the use of all
     2                 engineering controls before they are introduced
     3                 into the clinical setting.
     4                     (X)  Establishing an evaluation committee, at
     5                 least half the members of which are public front-
     6                 line health care workers from a variety of
     7                 occupational classifications and departments,
     8                 including nurses, nurse aides, technicians,
     9                 phlebotomists and physicians, to advise the
    10                 employer on the implementation of the
    11                 requirements of the regulations. Members of the
    12                 committee shall be trained in the proper method
    13                 of utilizing product evaluation criteria prior to
    14                 the commencement of product evaluation.
    15     (b)  Additional measures.--The department shall consider
    16  additional measures to prevent sharps injuries or exposure
    17  incidents. This subsection includes training and educational
    18  requirements, increased use of vaccinations, strategic placement
    19  of sharps containers as close to the work area as practical and
    20  increased use of personal protective equipment.
    21     (c)  Transitional period for certain drugs and biologics.--
    22  The use of a drug or biologic which is prepackaged with an
    23  administration system or used in a prefilled syringe and is
    24  approved for commercial distribution or investigational use by
    25  the Federal Food and Drug Administration is exempt for a
    26  standard adopted under subsection (a) or additional measures
    27  adopted under subsection (b) for a period of three years from
    28  the effective date of this act.
    29     (d)  Compilation and maintenance of list.--The department
    30  shall compile and maintain a list of needleless systems and
    20010H2124B2836                  - 6 -

     1  sharps with engineered sharps injury protection. The list shall
     2  be available to assist employers in complying with the
     3  requirements of the regulations promulgated under this section.
     4  The list may be developed from existing sources of information,
     5  including the Federal Food and Drug Administration, the Federal
     6  Centers for Disease Control, the National Institute of
     7  Occupational Safety and Health and the United States Department
     8  of Veterans Affairs.
     9  Section 4.  Fund.--
    10     (a)  Establishment.--The Bloodborne Pathogen Fund is
    11  established in the State Treasury.
    12     (b)  Purposes.--The department shall utilize the fund to do
    13  all of the following:
    14         (1)  Implement this act.
    15         (2)  In needleless systems and sharps with engineered
    16     sharps injury protection, provide for research, development
    17     and product evaluation.
    18     (c)  Source.--The source of the fund is appropriations.
    19     (d)  Continuous appropriation.--The money in the fund is
    20  continuously appropriated to the fund. This appropriation shall
    21  not lapse at the end of any fiscal year.
    22  Section 5.  Effective date.
    23     This act shall take effect in 120 days.





    J22L35BIL/20010H2124B2836        - 7 -